Waters' Q2 Revenues Inch up But Miss Analyst Estimates | GenomeWeb

NEW YORK (GenomeWeb News) – Waters today said that revenues for the second quarter inched up 1 percent, as the firm missed analyst estimates on the top line.

For the three months ended June 30, the firm posted revenues of $451.5 million, up just under 1 percent from $447.6 million for the second quarter of 2011, but missing Wall Street expectations of $458.4 million. Its organic growth for the quarter was 4 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.